Pain relieving block for patients of hernia surgery.

To evaluate the effect of quadratus lumborum block on tramadol sparing effect in patients undergoing open inguinal hernia surgery:A randomized controlled trial.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012011

Enrollment

Registered

2018-02-20

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: null- Patients who are undergoing unilateral open inguinal hernia surgeries of ASA grade 1 and 2.

Interventions

Intervention1: Group 1: Patients will receive single shot anterior quadratus lumborum block with 20 ml of 0.5% ropivacaine and dressing will be done at block site. Control Intervention1: Group 2: Pat

Eligibility

Inclusion criteria

Inclusion criteria: 1. ASA physical status I-II of both sexes. 2. Age between 18 to 80 years. 3. BMI >= 20 to 4. Scheduled for unilateral uncomplicated inguinal hernia surgery.

Exclusion criteria

Exclusion criteria: 1. Patient refusal for the study 2. Patients having history of substance abuse 3. Contraindication to spinal anaesthesia 4. Contraindication or allergy to local anaesthetics and tramadol 5. Pregnant and lactating women 6. Inability to understand functioning of PCA pump and VAS (visual analogue scale). 7. Infection at local surgical site.

Design outcomes

Primary

Measure	Time frame
Tramadol-sparing effect of quadratus lumborum (QL) block in post operative open inguinal hernia surgery patients.Timepoint: Post block,5,10,15minutes,1,4,8,12,18 and 24hr.	—

Secondary

Measure	Time frame
1.postoperative pain relief using visual analogue scale both at rest and movement. 2.haemodynamics(PR,BP and RR) 3.patient satisfaction score. 4.nausea and vomiting. 5.any other adverse effects.Timepoint: 1.Post block,5, 10,15 minutes ,1, 4, 8,12, 18,24 hrs and 3months.. 2 Post block,5, 10,15 minutes ,1, 4, 8,12, 18 and 24 hrs postoperatively. 3 At 24 hrs postoperatively and at 3 months. 4.Post block,5, 10,15 minutes ,1, 4, 8,12, 18 and 24 hrs postoperatively. 5.Post block,5, 10,15 minutes ,1, 4, 8,12, 18,24 hrs and 3months.	—

Measure

Time frame

1.postoperative pain relief using visual analogue scale both at rest and movement. 2.haemodynamics(PR,BP and RR) 3.patient satisfaction score. 4.nausea and vomiting. 5.any other adverse effects.Timepoint: 1.Post block,5, 10,15 minutes ,1, 4, 8,12, 18,24 hrs and 3months.. 2 Post block,5, 10,15 minutes ,1, 4, 8,12, 18 and 24 hrs postoperatively. 3 At 24 hrs postoperatively and at 3 months. 4.Post block,5, 10,15 minutes ,1, 4, 8,12, 18 and 24 hrs postoperatively. 5.Post block,5, 10,15 minutes ,1, 4, 8,12, 18,24 hrs and 3months.

—

Countries

India

Contacts

Public ContactVanita Ahuja

Government Medical College and Hospital,Sector-32,Chandigarh

vanitaanupam@gmail.com9646121649

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026